<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03358862</url>
  </required_header>
  <id_info>
    <org_study_id>SI-09-37</org_study_id>
    <nct_id>NCT03358862</nct_id>
  </id_info>
  <brief_title>Myopia Progression With a Novel Extended Depth of Focus Contact Lens</brief_title>
  <official_title>Myopia Progression in Children and Adolescents Before and After Use of a Novel Extended Depth of Focus Daily Disposable Soft Contact Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aller, Thomas A., OD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Visioneering Technologies, Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aller, Thomas A., OD</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Myopia has been increasing in prevalence and severity throughout the world over the last 30
      years. Increasing levels of myopia are associated with increased frequencies and severity of
      various ocular pathologies, including cataracts, glaucoma, retinal detachments and other
      retinal pathologies and myopic maculopathy. Slowing myopia progression at a young age before
      the eye reaches excessive axial length may help to reduce the future risks of these ocular
      pathologies.

      Conventional spectacles and contact lenses are prescribed correct myopia by moving the
      central focus of the eye for distance viewing from in front of the retina to on the retina
      centrally, or at the fovea. To varying degrees, these lenses allow the light to focus behind
      the retina, at varying peripheral retinal locations. These findings have led to efforts to
      design spectacle and contact lenses which correct peripheral hyperopic defocus, to reduce
      myopia progression.

      The consensus theory for how both multifocal contact lenses and orthokeratology can control
      myopia progression is that they each can reduce, eliminate, or reverse relative peripheral
      hyperopic defocus. Existing published studies on the use of multifocal contact lenses to
      control myopia in humans have utilized lenses with the distance correction in the center with
      peripheral plus power to correct the peripheral blur. Until recently, there have been no
      daily disposable multifocal lenses in the US market with distance center designs.

      The NaturalVue contact lens from Visioneering Technologies, Inc. is the first daily
      disposable distance center multifocal in the US. It has a novel extended depth of focus
      design where the distance correction is in the center of the optical zone, surrounded by a
      zone characterized by having a seamless, rapid transition from the distance power to a highly
      plus power at the edge of the optical zone.

      This study will analyze the myopia progression of patients in the investigator's practice
      while wearing their habitual visual corrections for periods up to two years prior to being
      switched to NaturalVue contact lenses. They will then be followed for up to two years after
      beginning use of this novel lens design and the differences in their myopia progression after
      versus before this novel lens will be analyzed. Axial lengths will be measured with the
      IOLMaster after switching to NaturalVue, at six-month intervals and will be compared to axial
      lengths which have been collected with habitual corrections.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Myopia has been increasing in prevalence and severity throughout the world over the last 30
      years. Increasing levels of myopia are associated with increased frequencies and severity of
      various ocular pathologies, including cataracts, glaucoma, retinal detachments and other
      retinal pathologies and myopic maculopathy. Slowing myopia progression at a young age before
      the eye reaches excessive axial length may help to reduce the future risks of these ocular
      pathologies.

      Conventional spectacles and contact lenses are prescribed to correct myopia by moving the
      central focus of the eye for distance viewing from in front of the retina to on the retina
      centrally, or at the fovea. To varying degrees, these lenses allow the light to focus behind
      the retina, at varying peripheral retinal locations. These findings have led to efforts to
      design spectacle and contact lenses which correct peripheral blur to reduce myopia
      progression.

      The consensus theory for how both multifocal contact lenses and orthokeratology can control
      myopia progression is that they each can reduce, eliminate, or reverse relative peripheral
      hyperopic defocus. Existing published studies on the use of multifocal contact lenses to
      control myopia in humans have utilized lenses with the distance correction in the center with
      peripheral plus power to correct the peripheral hyperopic defocus. Until recently, there have
      been no daily disposable multifocal lenses in the US market with distance center designs.

      The NaturalVue contact lens from Visioneering Technologies, Inc. is the first daily
      disposable distance center multifocal in the US. It has a novel extended depth of focus
      design where the distance correction is in the center of the optical zone, surrounded by a
      zone with a seamless, rapid transition from the distance power to a highly plus power at the
      edge of the optical zone.

      This study will analyze the myopia progression of patients in the investigator's practice
      while wearing their habitual visual corrections for periods up to two years prior to being
      switched to NaturalVue contact lenses. They will then be followed for up to two years after
      beginning use of this novel lens design and the differences in their myopia progression after
      NaturalVue versus before NaturalVue will be analyzed. Axial lengths will be measured with the
      IOLMaster after switching to NaturalVue, at six-month intervals and will be compared to axial
      lengths which have been collected with habitual corrections.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Anticipated">January 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Refractive error changes</measure>
    <time_frame>Data will be collected at baseline and at every six months.</time_frame>
    <description>Changes in myopia over time will be characterized by the spherical equivalent refractive error as measured by manifest subjective refraction.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Axial length of the eye</measure>
    <time_frame>Data will be collected at baseline and at every six months.</time_frame>
    <description>Changes in the axial length of the eye will be measured with the Zeiss IOLMaster</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Corneal curvature</measure>
    <time_frame>Data will be collected at baseline and at every six months</time_frame>
    <description>Keratometry will be measured by the Zeiss IOLMaster</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vitreous Chamber Depth</measure>
    <time_frame>Data will be collected at baseline and at every six months.</time_frame>
    <description>Vitreous Chamber Depth will be derived from measures of the Anterior Chamber Depth and the axial length as measured by the Zeiss IOLMaster.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Myopia</condition>
  <condition>Myopia, Progressive</condition>
  <arm_group>
    <arm_group_label>Myopes</arm_group_label>
    <description>Children, adolescents and young adults with existing progressive myopia equal to or exceeding -0.50 D in the year prior to beginning the use of the NaturalVue contact lens.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NaturalVue Multifocal Contact Lens</intervention_name>
    <description>NaturalVue multifocal contact lenses are daily disposable, distance center, multifocals with a novel extended depth of focus optical design. Patients wearing their habitual corrections who opt to change to this new lens will have their myopia progression monitored for up to two years.</description>
    <arm_group_label>Myopes</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study population will be drawn from the clinic of the principal investigator.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Myopic refractive error

          -  Astigmatism less than -2.50 D

          -  Evidence from clinical record of myopia progression equal to or greater than -0.50 D
             in at least one eye since the prior examination

          -  Ability to see 20/30 or better in the worse eye and 20/25 or better binocularly after
             one week adaptation

          -  Ability to properly insert, remove and care for study lens

        Exclusion Criteria:

          -  Moderate to severe allergic conjunctivitis

          -  Moderate to severe dry eyes

          -  Keratoconus or other related corneal irregularity

          -  Strabismus

          -  Amblyopia

          -  Nystagmus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas A Aller, OD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Independent</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dr. Thomas Aller Optometrist, Inc.</name>
      <address>
        <city>San Bruno</city>
        <state>California</state>
        <zip>94066</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Aller TA, Liu M, Wildsoet CF. Myopia Control with Bifocal Contact Lenses: A Randomized Clinical Trial. Optom Vis Sci. 2016 Apr;93(4):344-52. doi: 10.1097/OPX.0000000000000808.</citation>
    <PMID>26784710</PMID>
  </reference>
  <reference>
    <citation>Aller TA. Clinical management of progressive myopia. Eye (Lond). 2014 Feb;28(2):147-53. doi: 10.1038/eye.2013.259. Epub 2013 Dec 20. Review.</citation>
    <PMID>24357844</PMID>
  </reference>
  <reference>
    <citation>Aller TA, Wildsoet C. Bifocal soft contact lenses as a possible myopia control treatment: a case report involving identical twins. Clin Exp Optom. 2008 Jul;91(4):394-9. doi: 10.1111/j.1444-0938.2007.00230.x. Erratum in: Clin Exp Optom. 2008 Sep;91(5):479.</citation>
    <PMID>18601670</PMID>
  </reference>
  <reference>
    <citation>Cooper J, OÊ¼Connor B, Watanabe R, Fuerst R, Berger S, Eisenberg N, Dillehay SM. Case Series Analysis of Myopic Progression Control With a Unique Extended Depth of Focus Multifocal Contact Lens. Eye Contact Lens. 2017 Oct 19. doi: 10.1097/ICL.0000000000000440. [Epub ahead of print]</citation>
    <PMID>29053555</PMID>
  </reference>
  <reference>
    <citation>Woods J, Guthrie SE, Keir N, Dillehay S, Tyson M, Griffin R, Choh V, Fonn D, Jones L, Irving E. Inhibition of defocus-induced myopia in chickens. Invest Ophthalmol Vis Sci. 2013 Apr 12;54(4):2662-8. doi: 10.1167/iovs.12-10742.</citation>
    <PMID>23471891</PMID>
  </reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 26, 2017</study_first_submitted>
  <study_first_submitted_qc>November 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 2, 2017</study_first_posted>
  <last_update_submitted>November 30, 2017</last_update_submitted>
  <last_update_submitted_qc>November 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aller, Thomas A., OD</investigator_affiliation>
    <investigator_full_name>Thomas A. Aller, OD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>myopia</keyword>
  <keyword>progressive myopia</keyword>
  <keyword>contact lenses</keyword>
  <keyword>extended depth of focus</keyword>
  <keyword>retrospective clinical series</keyword>
  <keyword>axial length</keyword>
  <keyword>refractive error</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
    <mesh_term>Myopia, Degenerative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

